• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

建立切片培养作为研究癌症免疫微环境的工具。

Establishment of Slice Cultures as a Tool to Study the Cancer Immune Microenvironment.

作者信息

Jiang Xiuyun, Seo Y David, Sullivan Kevin M, Pillarisetty Venu G

机构信息

Department of Surgery, University of Washington School of Medicine, Seattle, WA, USA.

出版信息

Methods Mol Biol. 2019;1884:283-295. doi: 10.1007/978-1-4939-8885-3_20.

DOI:10.1007/978-1-4939-8885-3_20
PMID:30465211
Abstract

Although immunotherapy is currently being widely applied to treat a variety of cancers, there is great heterogeneity in the response to these treatments. Many in the field hypothesize that this may be attributable to the characteristics of each individual tumor immune microenvironment, in addition to systemic immune factors. Therefore, understanding the immune cell microenvironment in a variety of tumors is critically important. Specifically, the interactions among immune, stromal, and cancer cells, along with other factors in tumors, may hold the key to developing rational personalized combinations of immunotherapeutic drugs. We recently developed an organotypic slice culture technique, which enables precise study of the pancreatic ductal adenocarcinoma (PDA) tumor microenvironment. We used a Vibratome to cut fresh human tumor tissue into 250 μm thick slices, and cultured slices on cell culture inserts with 0.4 μm pore to produce our tumor slice culture (TSC) system. We showed that TSC maintained many elements of the original tumor microenvironment and architecture for approximately one week. Using this slice culture technique for PDA, we demonstrated that immune cells, including T cells and macrophages, cancer cells, and stromal myofibroblasts were present throughout the culture period. TSCs were functionally responsive to drug treatment. Live PDA slices could be stained for multicolor immunofluorescence imaging of each of the primary cellular constituents of the tumor. Finally, autologous CFSE-labeled splenocytes were observed to readily migrate into cocultured tumor slices.

摘要

尽管免疫疗法目前正广泛应用于治疗多种癌症,但这些治疗的反应存在很大的异质性。该领域的许多人推测,除了全身免疫因素外,这可能归因于每个肿瘤免疫微环境的特征。因此,了解各种肿瘤中的免疫细胞微环境至关重要。具体而言,免疫细胞、基质细胞和癌细胞之间的相互作用,以及肿瘤中的其他因素,可能是开发合理的个性化免疫治疗药物组合的关键。我们最近开发了一种器官型切片培养技术,能够精确研究胰腺导管腺癌(PDA)肿瘤微环境。我们使用振动切片机将新鲜的人类肿瘤组织切成250μm厚的切片,并在孔径为0.4μm的细胞培养插入物上培养切片,以产生我们的肿瘤切片培养(TSC)系统。我们表明,TSC在大约一周的时间内维持了原始肿瘤微环境和结构的许多要素。使用这种针对PDA的切片培养技术,我们证明了在整个培养期间都存在免疫细胞(包括T细胞和巨噬细胞)、癌细胞和基质肌成纤维细胞。TSC对药物治疗具有功能反应性。活的PDA切片可以进行染色,以便对肿瘤的每种主要细胞成分进行多色免疫荧光成像。最后,观察到自体CFSE标记的脾细胞能够轻易迁移到共培养的肿瘤切片中。

相似文献

1
Establishment of Slice Cultures as a Tool to Study the Cancer Immune Microenvironment.建立切片培养作为研究癌症免疫微环境的工具。
Methods Mol Biol. 2019;1884:283-295. doi: 10.1007/978-1-4939-8885-3_20.
2
Organotypic slice cultures of pancreatic ductal adenocarcinoma preserve the tumor microenvironment and provide a platform for drug response.胰腺导管腺癌的器官型切片培养物保留了肿瘤微环境,并为药物反应提供了一个平台。
Pancreatology. 2018 Dec;18(8):913-927. doi: 10.1016/j.pan.2018.09.009. Epub 2018 Sep 26.
3
Long-lived pancreatic ductal adenocarcinoma slice cultures enable precise study of the immune microenvironment.长期存活的胰腺导管腺癌切片培养物能够精确研究免疫微环境。
Oncoimmunology. 2017 May 25;6(7):e1333210. doi: 10.1080/2162402X.2017.1333210. eCollection 2017.
4
Local and systemic immunosuppression in pancreatic cancer: Targeting the stalwarts in tumor's arsenal.胰腺癌的局部和全身免疫抑制:靶向肿瘤武器库中的中坚力量。
Biochim Biophys Acta Rev Cancer. 2020 Aug;1874(1):188387. doi: 10.1016/j.bbcan.2020.188387. Epub 2020 Jun 21.
5
Rational combinations of immunotherapy for pancreatic ductal adenocarcinoma.胰腺导管腺癌免疫治疗的合理联合方案
Chin Clin Oncol. 2017 Jun;6(3):31. doi: 10.21037/cco.2017.06.04.
6
Development of primary human pancreatic cancer organoids, matched stromal and immune cells and 3D tumor microenvironment models.原发性人胰腺癌细胞类器官、匹配的基质和免疫细胞及 3D 肿瘤微环境模型的开发。
BMC Cancer. 2018 Mar 27;18(1):335. doi: 10.1186/s12885-018-4238-4.
7
Development of human pancreatic cancer avatars as a model for dynamic immune landscape profiling and personalized therapy.开发人类胰腺癌细胞类器官作为动态免疫图谱分析和个体化治疗的模型。
Sci Adv. 2024 Jul 5;10(27):eadm9071. doi: 10.1126/sciadv.adm9071.
8
A Brain Tumor/Organotypic Slice Co-culture System for Studying Tumor Microenvironment and Targeted Drug Therapies.一种用于研究肿瘤微环境和靶向药物治疗的脑肿瘤/器官型切片共培养系统
J Vis Exp. 2015 Nov 7(105):e53304. doi: 10.3791/53304.
9
Ex vivo organotypic culture system of precision-cut slices of human pancreatic ductal adenocarcinoma.人胰腺导管腺癌的离体器官型培养系统。
Sci Rep. 2019 Feb 14;9(1):2133. doi: 10.1038/s41598-019-38603-w.
10
An Immunological Glance on Pancreatic Ductal Adenocarcinoma.胰腺导管腺癌的免疫学观察。
Int J Mol Sci. 2020 May 8;21(9):3345. doi: 10.3390/ijms21093345.

引用本文的文献

1
Cancer Organoids as reliable disease models to drive clinical development of novel therapies.癌症类器官作为推动新型疗法临床开发的可靠疾病模型。
J Exp Clin Cancer Res. 2024 Dec 28;43(1):334. doi: 10.1186/s13046-024-03258-7.
2
Bioengineering and omics approaches for Type 1 diabetes practical research: advancements and constraints.1型糖尿病实践研究的生物工程与组学方法:进展与局限
Ann Med. 2025 Dec;57(1):2322047. doi: 10.1080/07853890.2024.2322047. Epub 2024 Dec 20.
3
Patient-derived tumor organoids: A preclinical platform for personalized cancer therapy.
患者来源的肿瘤类器官:个性化癌症治疗的临床前平台。
Transl Oncol. 2025 Jan;51:102226. doi: 10.1016/j.tranon.2024.102226. Epub 2024 Dec 1.
4
Glioma stem cells remodel immunotolerant microenvironment in GBM and are associated with therapeutic advancements.神经胶质瘤干细胞重塑胶质母细胞瘤中的免疫耐受微环境,并与治疗进展相关。
Cancer Biomark. 2024;41(1):1-24. doi: 10.3233/CBM-230486.
5
Advancements in 3D In Vitro Models for Colorectal Cancer.结直肠癌的 3D 体外模型的进展。
Adv Sci (Weinh). 2024 Aug;11(32):e2405084. doi: 10.1002/advs.202405084. Epub 2024 Jul 4.
6
Cytotoxic response of tumor-infiltrating lymphocytes of head and neck cancer slice cultures under mitochondrial dysfunction.线粒体功能障碍下头颈部癌切片培养物中肿瘤浸润淋巴细胞的细胞毒性反应
Front Oncol. 2024 Mar 7;14:1364577. doi: 10.3389/fonc.2024.1364577. eCollection 2024.
7
Reversing immunosuppression in the tumor microenvironment of fibrolamellar carcinoma via PD-1 and IL-10 blockade.通过 PD-1 和 IL-10 阻断逆转纤维板层样肝癌肿瘤微环境中的免疫抑制。
Sci Rep. 2024 Mar 1;14(1):5109. doi: 10.1038/s41598-024-55593-6.
8
GITR and TIGIT immunotherapy provokes divergent multicellular responses in the tumor microenvironment of gastrointestinal cancers.GITR 和 TIGIT 免疫疗法在胃肠道癌的肿瘤微环境中引发了不同的多细胞反应。
Genome Med. 2023 Nov 26;15(1):100. doi: 10.1186/s13073-023-01259-3.
9
The challenge of making the right choice: patient avatars in the era of cancer immunotherapies.做出正确选择的挑战:癌症免疫疗法时代的患者化身。
Front Immunol. 2023 Aug 10;14:1237565. doi: 10.3389/fimmu.2023.1237565. eCollection 2023.
10
Production of an interleukin-10 blocking antibody by genetically engineered macrophages increases cancer cell death in human gastrointestinal tumor slice cultures.基因工程巨噬细胞产生的白细胞介素-10 阻断抗体增加了人胃肠道肿瘤切片培养物中的癌细胞死亡。
Cancer Gene Ther. 2023 Sep;30(9):1227-1233. doi: 10.1038/s41417-023-00632-z. Epub 2023 Jun 9.